Merit Medical Systems Inc
MMSI87.390USD
-0.240-0.27%
Handelsschluss 12/24, 16:00（ET）Kurse um 15 Minuten verzögert
5.18BMarktkapitalisierung
43.52KGV TTM
mehr Informationen über Merit Medical Systems Inc Unternehmen
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Merit Medical Systems Inc Informationen
BörsenkürzelMMSI
Name des UnternehmensMerit Medical Systems Inc
IPO-datumOct 22, 2090
CEOAronson (Martha Goldberg)
Anzahl der mitarbeiter7400
WertpapierartOrdinary Share
GeschäftsjahresendeOct 22
Addresse1600 West Merit Park Way
StadtSOUTH JORDAN
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl84095
Telefon18012531600
Websitehttps://www.merit.com/
BörsenkürzelMMSI
IPO-datumOct 22, 2090
CEOAronson (Martha Goldberg)
Führungskräfte von Merit Medical Systems Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.09M
-5.23%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
Nach RegionUSD
Name
Umsatz
Anteil
United States
227.08M
59.37%
International
155.38M
40.63%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
Aktionärsstatistik
Aktualisiert: Tue, Nov 18
Aktualisiert: Tue, Nov 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Andere
64.97%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.34%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.71%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.11%
Andere
64.97%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
54.11%
Investment Advisor/Hedge Fund
32.95%
Hedge Fund
10.11%
Research Firm
3.04%
Bank and Trust
2.31%
Individual Investor
2.26%
Pension Fund
1.63%
Sovereign Wealth Fund
1.02%
Family Office
0.40%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Nomura Investment Management Business Trust
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Institutional Asset Management
1.09M
1.85%
-3.11K
-0.28%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
Invesco S&P SmallCap Health Care ETF
3.18%
First Trust Indxx Medical Devices ETF
2.22%
State Street SPDR S&P Health Care Equipment ETF
1.76%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
0.71%
OneAscent Enhanced Small and Mid Cap ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
iShares S&P Small-Cap 600 Growth ETF
0.66%
Franklin US Small Cap Multifactor Index ETF
0.66%
Mehr Anzeigen
Invesco S&P SmallCap Health Care ETF
Anteil3.18%
First Trust Indxx Medical Devices ETF
Anteil2.22%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.76%
Thrivent Small-Mid Cap ESG ETF
Anteil0.91%
Invesco S&P SmallCap Low Volatility ETF
Anteil0.77%
State Street SPDR S&P 600 Small Cap Growth ETF
Anteil0.71%
OneAscent Enhanced Small and Mid Cap ETF
Anteil0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Anteil0.67%
iShares S&P Small-Cap 600 Growth ETF
Anteil0.66%
Franklin US Small Cap Multifactor Index ETF
Anteil0.66%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Merit Medical Systems Inc?
Die fünf größten Anteilseigner von Merit Medical Systems Inc sind:
BlackRock Institutional Trust Company, N.A. hält 7.97M Aktien, was 13.46% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 6.82M Aktien, was 11.51% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 2.22M Aktien, was 3.75% der Gesamtaktien entspricht.
Conestoga Capital Advisors, LLC hält 2.21M Aktien, was 3.73% der Gesamtaktien entspricht.
Fuller & Thaler Asset Management Inc. hält 1.82M Aktien, was 3.07% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 7.97M Aktien, was 13.46% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 6.82M Aktien, was 11.51% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 2.22M Aktien, was 3.75% der Gesamtaktien entspricht.
Conestoga Capital Advisors, LLC hält 2.21M Aktien, was 3.73% der Gesamtaktien entspricht.
Fuller & Thaler Asset Management Inc. hält 1.82M Aktien, was 3.07% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Merit Medical Systems Inc?
Die drei wichtigsten Anteilseigner-Typen von Merit Medical Systems Inc sind:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an Merit Medical Systems Inc (MMSI)?
Mit Stand vom 2025Q3 halten 736 Institutionen Anteile an Merit Medical Systems Inc, mit einem Gesamtmarktwert von etwa 64.29M, was 108.43% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -2.37% gestiegen.
Was ist die größte Einnahmequelle von Merit Medical Systems Inc?
Am FY2025Q2 erzielte das Geschäft mit Peripheral Intervention für Merit Medical Systems Inc den höchsten Umsatz in Höhe von 142.85M, was 37.35% des Gesamtumsatzes entspricht.
